SUNNYVALE, Calif., and WILMINGTON, N.C. — Viewics, a healthcare-focused insights company that provides hospitals and health systems with laboratory-driven solutions for advanced analytics, today announced that it has signed an agreement to make its solutions available to members of the…
Supply Chain
The American Red Cross is still low on blood donations after a serious shortage this summer, said Christy McPeters, a spokeswoman for the Red Cross.
The Food and Drug Administration recently approved Ahead 300, a handheld medical device that helps clinicians diagnose a traumatic brain injury.
When Mylan CEO Heather Bresch testified before the House Oversight Committee Sept. 21, she told lawmakers the company makes $100 in profit off a two-pack of EpiPens listed at $608. However, Ms. Bresch failed to indicate this number was estimated…
After VanMoof realized its high-end bikes kept getting damaged when shipped to customers, the Amsterdam-based bicycle manufacturer came up with a simple fix: print an image of a flat screen TV on the side of their boxes.
Advertisement
The Food and Drug Administration approved expanded treatment uses for the anti-inflammatory drug llaris, developed by Basel, Switzerland-based Novartis.
Pfizer said it will not split into two publicly traded companies — one for brand name drugs and one for generics — after finding the move would not benefit shareholders, reported Reuters.
The Healthcare Distribution Alliance elected Jon Giacomin chairman of its board of directors.
The Food and Drug Administration Friday approved Amjevita, a biosimilar copy of Abbvie's best-selling arthritis drug Humira.
The Food and Drug Administration granted priority review status to dupilumab, an injectable antibody drug used to treat atopic dermatitis, or eczema.